Similarly, IRF2BP2::CDX1 fusion has been recently described in rare mesenchymal chondrosarcoma cases [21, 22]; Patton et al. recently reported a variant fusion in an intravascular myoepithelioma [26]. Here, IRF2BP2 is linked to myoepithelial tumor.